NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December 31, 2019 on Monday, March 2, 2020 after market close. The Company will host a conference call to discuss these results at 5:00…
Cowen downgraded Aurora Cannabis Inc. , Tilray Inc. and Sundial Growers Inc. to market perform from outperform on Monday, and said it’s increasingly cautious on the outlook for cannabis in Canada. Analyst Vivien Azer said the headwinds that have rocked the sector from pricing to too few stores to inventory do not appear to be easing and Cannabis 2.0, the…
Investors are bracing for more job cuts and writedowns at Canadian cannabis producers before the industry stabilizes and becomes profitable, after two of the biggest weed companies, Aurora Cannabis and Tilray announced cost reductions this week. Canada legalized recreational cannabis in October 2018 but profits have proven elusive for most marijuana companies as fewer-than-expected retail stores, higher prices than on…
Licensed producer Tilray Inc. announced late Tuesday afternoon that it will be laying off 10 per cent of its staff, in an effort to cut costs. “By reducing headcount and cost, Tilray will be better positioned to achieve profitability,” CEO Brendan Kennedy said in a statement released by the company. Tilray employs 1,443 people globally, with a majority of them…
Tilray said it would focus on international medical cannabis, science and research, Canadian recreational use, and its Manitoba Harvest hemp foods. “The tough decision to eliminate roles has not been taken lightly,” Kennedy continued. READ MORE: https://finance.yahoo.com/m/efeed1da-c4be-3baa-8d64-888b20625569/marijuana-stock-tilray-is.html?.tsrc=rss
Tilray® Expands Global Leadership Team with New COO and CFO Former Revlon executive, Jon Levin, joins as Chief Operating Officer and former Molson Coors and Pharmaca executive, Michael Kruteck joins as Chief Financial Officer Current Tilray CFO, Mark Castaneda, to stay on in strategic business development role NANAIMO, British Columbia-January 14, 2020-(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: […] READ MORE: https://www.newcannabisventures.com/tilray-adds-cpg-veterans-to-its-senior-leadership/
NANAIMO, British Columbia–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TILRAY EXPORTS FIRST-EVER COMMERCIAL SHIPMENT OF MEDICAL CANNABIS ALLOWED INTO ISRAEL Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates from Tilray’s Portugal facility; Tilray…
NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into a agreement with Canndoc Ltd., (“Canndoc”), a wholly-owned subsidiary of InterCure Ltd. (TASE: INCR), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export a wholesale shipment of up to 2.5 tonnes of medical cannabis from…
High Park™ Reveals its New Portfolio of “Cannabis 2.0” Brands and Products New portfolio additions include edibles, confectionery goods, CBD-beverages and more, expanding High Park’s existing broad-based portfolio of brands and products TORONTO, December 17, 2019–(BUSINESS WIRE)–Today, High Park Holdings Ltd. (“High Park”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY), proudly introduces its phase two […] READ MORE: https://www.newcannabisventures.com/tilray-unveils-next-gen-cannabis-products/
NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that the merger with Privateer Holdings, Inc. (“Privateer”), closed on December 12, 2019. Mark Castaneda, Chief Financial Officer of Tilray, said: “We appreciate the long-term confidence that Privateer has in the Tilray business and we look forward to…
Tilray (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, on Wednesday announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. (“Tilray Portugal”) has received its Good Manufacturing Practice (“GMP”) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. According to the update, Infarmed, the Portuguese National Authority of Medicines and Health Products,…
Cannabis stocks fell for a third straight session on Wednesday, as Tilray’s mixed third-quarter earnings failed to light a fire under the battered sector. READ MORE: https://finance.yahoo.com/m/1603de78-d346-3018-9ca9-a2a6e55baf20/cannabis-stocks-slide-for.html?.tsrc=rss